OrganiGram Holdings Total Liabilities 2011-2025 | OGI

Annual Total Liabilities OrganiGram Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
102 M	26.8 M	69 M	74.2 M	136 M	102 M	118 M	9.78 M	9.61 M	6.32 M	115 K	73 K	39.6 K	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
136 M	39.6 K	50.2 M

Quarterly Total Liabilities OrganiGram Holdings

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	74.2 M	-	-	-	136 M	-	-	-	102 M	-	-	-	118 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
136 M	74.2 M	107 M

Total Liabilities of other stocks in the Drug manufacturers industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	107 M	-	-	$ 142 M	USA
Assertio Holdings ASRT	148 M	$ 0.75	-2.02 %	$ 53.3 M	USA
Cronos Group CRON	218 M	$ 3.09	-5.64 %	$ 1.66 B	Canada
Aerie Pharmaceuticals AERI	449 M	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	430 M	$ 1.66	-4.48 %	$ 179 M	Canada
AcelRx Pharmaceuticals ACRX	10.2 M	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	11.6 M	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	26.6 M	-	10.11 %	$ 58.2 M	USA
Aurora Cannabis ACB	244 M	$ 5.22	-3.33 %	$ 86.3 M	Canada
Catalent CTLT	6.15 B	-	-	$ 11.5 B	USA
Calliditas Therapeutics AB (publ) CALT	250 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	367 M	-	2.45 %	$ 38.1 M	Canada
DURECT Corporation DRRX	63.2 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	173 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	10.3 B	-	-	$ 28.9 M	Irlanda
Emergent BioSolutions EBS	1.17 B	$ 11.91	4.29 %	$ 610 M	USA
Organogenesis Holdings ORGO	113 M	$ 4.91	1.76 %	$ 647 M	USA
Pacira BioSciences PCRX	775 M	$ 26.42	0.49 %	$ 1.22 B	USA
Evoke Pharma EVOK	9.65 M	$ 10.97	0.18 %	$ 36.7 M	USA
Athenex ATNX	228 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	90.4 M	$ 21.45	0.4 %	$ 2.04 B	France
Rockwell Medical RMTI	30.9 M	$ 0.9	-2.78 %	$ 21 M	USA
Evolus EOLS	227 M	$ 7.2	2.2 %	$ 447 M	USA
Harrow Health HROW	242 M	$ 46.39	-1.43 %	$ 1.51 B	USA
Sonoma Pharmaceuticals SNOA	9.28 M	$ 3.55	-1.11 %	$ 4.41 M	USA
China Pharma Holdings CPHI	7.14 M	$ 1.53	-1.92 %	$ 26.7 M	China
Bausch Health Companies BHC	27.4 B	$ 6.79	-1.95 %	$ 2.48 B	Canada
Veru VERU	28.1 M	$ 2.39	-1.15 %	$ 322 M	USA
Lannett Company LCI	735 M	-	1.15 %	$ 7.11 M	USA
Cumberland Pharmaceuticals CPIX	53 M	$ 2.96	17.0 %	$ 41.6 M	USA
Neoleukin Therapeutics NLTX	36.5 M	-	-	$ 193 M	Canada
Solid Biosciences SLDB	51.4 M	$ 5.79	-1.36 %	$ 236 M	USA
PetIQ PETQ	478 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	12.2 M	$ 4.05	-0.25 %	$ 122 M	USA
Jupiter Wellness JUPW	9.51 M	-	-	$ 33.6 M	USA
Perrigo Company plc PRGO	5.33 B	$ 12.99	-1.14 %	$ 1.78 B	USA
ProPhase Labs PRPH	24 M	$ 0.11	-0.35 %	$ 1.74 M	USA
Radius Health RDUS	434 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	94.8 M	-	-4.76 %	$ 65.3 M	USA
cbdMD YCBD	8.62 M	$ 1.59	30.33 %	$ 6.86 M	USA
Sundial Growers SNDL	216 M	$ 2.09	-5.49 %	$ 3.37 M	Canada
OptiNose OPTN	194 M	-	-	$ 1.08 B	USA
PLx Pharma PLXP	25 M	-	-27.8 %	$ 2.56 M	USA
SCYNEXIS SCYX	55.4 M	$ 0.64	-1.49 %	$ 30.6 M	USA
Tricida TCDA	168 M	-	-	$ 3.25 M	USA
Tilray TLRY	977 M	$ 11.19	-7.9 %	$ 6.92 B	Canada
TherapeuticsMD TXMD	14 M	$ 1.74	-0.86 %	$ 18.2 M	USA
Zomedica Corp. ZOM	13.2 M	-	-0.21 %	$ 98 M	USA
Viatris VTRS	28.9 B	$ 11.71	0.47 %	$ 14.2 B	USA